Epilepsy and migraine as comorbid disorders: Epidemiologic perspectives

Advanced Studies in Medicine

Volumn 5, Issue 6 E, 2005, Pages

  Lipton, Richard B ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; COMORBIDITY; CONFERENCE PAPER; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; EPILEPSY; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MIGRAINE; NERVE CELL EXCITABILITY; PATHOPHYSIOLOGY; RISK FACTOR; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME;

EID: 23044482874     PISSN: 15303004     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (63)

1. Welch KM, Levine SR. Migraine-related stroke in the context of the International Headache Society classification of head pain. Arch Neurol. 1990;47(4):458-462.
2. Henrich JB, Horwitz RI. A controlled study of ischemic stroke risk in migraine patients. J Clin Epidemiol. 1989;42(8):773-780.
3. Marini C, Carolei A, Roberts RS, et al. Focal cerebral ischemia in young adults: a collaborative case-control study. The National Research Council Study Group. Neuroepidemiology. 1993;12(2):70-81.
4. Tzourio C, Iglesias S, Hubert JB, et al. Migraine and risk of ischaemic stroke: a case-control study. BMJ. 1993;307(6899):289-292.
5. Tzourio C, Tehindrazanarivelo A, Iglesias S, et al. Case-control study of migraine and risk of ischaemic stroke in young women. BMJ. 1995;310(6983):820- 833.
6. Breslau N, Merikangas K, Bowden CL. Comorbidity of migraine and major affective disorders. Neurology. 1994;44(10, suppl 7):S17-S22.
7. Low NC, Merikangas KR. The comorbidity of migraine. CNS Spectr. 2003;8(6):433-434, 437-444.
8. Breslau N, Lipton RB, Stewart WF, Schultz LR, Welch KM. Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology. 2003;60(8):1308-1312.
9. Merikangas KR, Merikangas JR, Angst J. Headache syndromes and psychiatric disorders: association and familial transmission. J Psychiatr Res. 1993;27(2):197-210.
10. McElroy SL. Diagnosing and treating comorbid (complicated) bipolar disorder. J Clin Psychiatry. 2004;65(suppl 15):35-44.
11. Harter MC, Conway KP, Merikangas KR. Associations between anxiety disorders and physical illness. Eur Arch Psychiatry Clin Neurosci. 2003;253(6):313-320.
12. Sheftell FD, Atlas SJ. Migraine and psychiatric comorbidity: from theory and hypotheses to clinical application. Headache. 2002;42(9):934-944.
13. Marazziti D, Toni C, Pedri S, et al. Headache, panic disorder and depression: comorbidity or a spectrum? Neuropsychobiology. 1995;31(3):125-129.
14. Boro A, Haut S. Medical comorbidities in the treatment of epilepsy. Epilepsy Behav. 2003;4(suppl 2):S2-S12.
15. Montagna P. The physiopathology of migraine: the contribution of genetics. Neurol Sci. 2004;25(suppl 3):S93-S96.
16. Lipton RB, Liberman JN, Kolodner KB, Bigal ME, Dowson A, Stewart WF. Migraine headache disability and health-related quality-of-life: a population-based case-control study from England. Cephalalgia. 2003;23(6):441-450.
17. Lipton RB, Hamelsky SW, Kolodner KB, Steiner TJ, Stewart WF. Migraine, quality of life, and depression: a population-based case-control study. Neurology. 2000;55(5):629-635.
18. Beghi E, Roncolato M, Visona G. Depression and altered quality of life in women with epilepsy of childbearing age. Epilepsia. 2004;45(1):64-70.
19. Loring DW, Meador KJ, Lee GP. Determinants of quality of life in epilepsy. Epilepsy Behav. 2004;5(6):976-980.
20. Gutierrez-Delicado E, Serratosa JM. Genetics of the epilepsies. Curr Opin Neurol. 2004;17(2):147-153.
21. Andermann E, Andermann F. Migraine-epilepsy relationships: epidemiological and genetic aspects. In: Andermann FA, Lugaresi E, eds. Migraine and Epilepsy. Boston, Mass: Butterworths; 1987:281-291.
22. Hauser WA, Annegers JF, Kurland LT. Prevalence of epilepsy in Rochester, Minnesota: 1940-1980. Epilepsia. 1991;32(4):429-445.
23. Ottman R, Lipton RB. Comorbidity of migraine and epilepsy. Neurology. 1994;44(11):2105-2110.
24. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA. 1992;267(1):64-69.
25. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41(7):646-657.
26. Lipton RB, Ottman R, Ehrenberg BL, Hauser WA. Comorbidity of migraine: the connection between migraine and epilepsy. Neurology. 1994;44(10, suppl 7):S28-S32.
27. Ottman R, Lipton RB. Is the Comorbidity of epilepsy and migraine due to a shared genetic susceptibility? Neurology. 1996;47(4):918-924.
28. Welch KM. Contemporary concepts of migraine pathogenesis. Neurology. 2003;61(8, suppl 4):S2-S8.
29. McKendrick AM, Badcock DR. Motion processing deficits in migraine. Cephalalgia. 2004;24(5):363-372.
30. Huang J, Cooper TG, Satana B, Kaufman DI, Cao Y. Visual distortion provoked by a stimulus in migraine associated with hyperneuronal activity. Headache. 2003;43(6):664-671.
31. Chronicle EP, Mulleners WM. Visual system dysfunction in migraine: a review of clinical and psychophysical findings. Cephalalgia. 1996;16(8):525-535.
32. Parsons AA. Cortical spreading depression: its role in migraine pathogenesis and possible therapeutic intervention strategies. Curr Pain Headache Rep. 2004;8(5):410-416.
33. Cao Y, Aurora SK, Nagesh V, Patel SC, Welch KM. Functional MRI-BOLD of brainstem structures during visually triggered migraine. Neurology. 2002;59(1):72-78.
34. Cutrer FM, O'Donnell A, Sanchez del Rio M. Functional neuroimaging: enhanced understanding of migraine pathophysiology. Neurology. 2000;55(9, suppl 2):S36-S45.
35. Calandre EP, Bembibre J, Arnedo ML, Becerra D. Cognitive disturbances and regional cerebral blood flow abnormalities in migraine patients: their relationship with the clinical manifestations of the illness. Cephalalgia. 2002;22(4):291-302.
36. Bowyer SM, Aurora KS, Moran JE, Tepley N, Welch KM. Magnetoencephalographic fields from patients with spontaneous and induced migraine aura. Ann Neurol. 2001;50(5):582-587.
37. Young WB, Oshinsky ML, Shechter AL, Gebeline-Myers C, Bradley KC, Wassermann EM. Consecutive transcranial magnetic stimulation: phosphene thresholds in migraineurs and controls. Headache. 2004;44(2):131-135.
38. Ambrosini A, Schoenen J. The electrophysiology of migraine. Curr Opin Neurol. 2003;16(3):327-331.
39. Aurora SK, Welch KM, Al-Sayed F. The threshold for phosphenes is lower in migraine. Cephalalgia. 2003;23(4):258-263.
40. Ozturk V, Cakmur R, Donmez B, Yener GG, Kursad F, Idiman F. Comparison of cortical excitability in chronic migraine (transformed migraine) and migraine without aura. A transcranial magnetic stimulation study. J Neurol. 2002;249(9):1208-1271.
41. Brighina F, Piazza A, Daniele O, Fierro B. Modulation of visual cortical excitability in migraine with aura: effects of 1 Hz repetitive transcranial magnetic stimulation. Exp Brain Res. 2002;145(2):177-181.
42. Battelli L, Black KR, Wray SH. Transcranial magnetic stimulation of visual area V5 in migraine. Neurology. 2002;58(7):1000-1009.
43. Aurora SK, Cao Y, Bowyer SM, Welch KM. The occipital cortex is hyperexcitable in migraine: experimental evidence. Headache. 1999;39(7):469-476.
44. Mulleners WM, Chronicle EP, Palmer JE, Koehler PJ, Vredeveld JW. Visual cortex excitability in migraine with and without aura. Headache. 2001;41(6):565-572.
45. Kropp P, Gerber WD. Prediction of migraine attacks using a slow cortical potential, the contingent negative variation. Neurosci Lett. 1998;257(2):73-76.
46. Kropp P, Gerber WD. Contingent negative variation-findings and perspectives in migraine. Cephalalgia. 1993;13(1):33-36.
47. Bocker KB, Timsit-Berthier M, Schoenen J, Brunia CH. Contingent negative variation in migraine. Headache. 1990;30(9):604-609.
48. Siniatchkin M, Kropp P, Gerber WD. What kind of habituation is impaired in migraine patients? Cephalalgia. 2003;23(7):511-518.
49. Evers S, Bauer B, Grotemeyer KH, Kurlemann G, Husstedt IW. Event-related potentials (P300) in primary headache in childhood and adolescence. J Child Neurol. 1998;13(7):322-326.
50. Mazzotta G, Alberti A, Santucci A, Gallai V. The event-related potential P300 during headache-free period and spontaneous attack in adult headache sufferers. Headache. 1995;35(4):210-215.
51. Klopstock T, May A, Seibel P, Papagiannuli E, Diener HC, Reichmann H. Mitochondrial DNA in migraine with aura. Neurology. 1996;46(6):1735-1738.
52. Terwindt GM, Ophoff RA, Haan J, et al. Variable clinical expression of mutations in the P/Q-type calcium channel gene in familial hemiplegic migraine. Dutch Migraine Genetics Research Group. Neurology. 1998;50(4):1105-1110.
53. van den Maagdenberg AM, Pietrobon D, Pizzorusso T, et al. A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron. 2004;41(5):701-710.
54. Boska MD, Welch KM, Barker PB, Nelson JA, Schultz L. Contrasts in cortical magnesium, phospholipid and energy metabolism between migraine syndromes. Neurology. 2002;58(8):1227-1233.
55. Durlach J, Pages N, Bac P, Bara M, Guiet-Bara A, Agrapart C. Chronopathological forms of magnesium depletion with hypofunction or with hyperfunction of the biological clock. Magnes Res. 2002;15(3-4):263-268.
56. Durlach J, Pages N, Bac P, Bara M, Guiet-Bara A. Importance of magnesium depletion with hypofunction of the biological clock in the pathophysioiogy of headhaches with photophobia, sudden infant death and some clinical forms of multiple sclerosis. Magnes Res. 2004;17(4):314-326.
57. Bussone G. Pathophysioiogy of migraine. Neurol Sci. 2004;25(suppl 3):S239-S241.
58. Tepper SJ, Rapoport A, Sheftell F. The pathophysioiogy of migraine. Neurologist. 2001;7(5):279-286.
59. Bigal ME, Bordini CA, Tepper SJ, Speciali JG. Intravenous magnesium sulphate in the acute treatment of migraine with out aura and migraine with aura. A randomized, double-blind, placebo-controlled study. Cephalalgia. 2002;22(5):345-353.
60. Scher AI, Stewart WF, Ricci JA, Lipton RB. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain. 2003;106(1-2):81-89.
61. Scher AI, Stewart WF, Lipton RB. Caffeine as a risk factor for chronic daily headache: a population-based study. Neurology. 2004;63(11):2022-2027.
62. Scher AI, Lipton RB, Stewart WF. Habitual snoring as a risk factor for chronic daily headache. Neurology. 2003;60(8):1300-1368.
63. Scher AI, Lipton RB, Stewart W. Risk factors for chronic daily headache. Curr Pain Headache Rep. 2002;6(6):486-491.